An expert calls for change in the way researchers and pharmaceutical companies collect and report adverse symptom information in clinical trials submitted to the Food and Drug Administration, and how the FDA represents this information on drug labels.
Patient safety reporting and drug label accuracy missing vital information, expert says
Submitted by synapse on
Add new comment